Evidence also has shown that the use of high-dose glucocorticoids in GCA patients significantly decreases levels of IL-6 (effectively decreasing levels of acute-phase reactants) but has no effect on IFN-gamma levels [1]. This evidence concerns the gene IL6 and temporal arteritis.